EU Health Ministers Discuss Proposal to Restrict Nicotine Product Flavors

Regulations by 2FIRSTS.ai
Jun.21.2024
EU Health Ministers Discuss Proposal to Restrict Nicotine Product Flavors
EU health ministers discuss proposals to restrict e-cigarette and nicotine product flavors, potentially affecting millions of consumers.

According to a report by Vaping360 on June 21st, today (the 21st), health ministers from all 27 European Union (EU) member states discussed proposals to restrict e-cigarette and other nicotine product flavors (including nicotine pouches). Their stance could lead to stricter regulations on e-cigarettes for millions of nicotine consumers in Europe.

 

The Employment, Social Policy, Health, and Consumer Affairs Committee (EPSCO), one of the 10 "agencies" of the European Commission, will consider proposals from Latvia and Denmark to support a ban on flavorings and crack down on cross-border sales within the EU.

 

Latvia's proposal also received support from delegations from Cyprus, Estonia, Ireland, Lithuania, Luxembourg, Malta, Portugal, Slovenia, and Spain. Denmark's suggestion was endorsed by Estonia, Finland, France, Germany, Ireland, Luxembourg, Malta, the Netherlands, Poland, Slovenia, and Spain.

 

If the health ministers reach a consensus on these proposals, the next step will be to ask the European Commission to draft legislation, which will ultimately be voted on by the Council and the European Parliament. During this process, elections in various countries may soften or strengthen support for bans on certain flavors.

 

Currently, seven countries in the European Union have passed laws banning e-cigarette flavors: Denmark, Estonia, Finland, Hungary, Lithuania, the Netherlands, and Slovenia. Spain recently completed a public consultation on a proposal to ban flavors, while Latvia is introducing flavor restrictions. Currently, no European country has passed a total ban on e-cigarettes.

 

The existing Tobacco Products Directive (TPD) regulates nicotine and tobacco product standards within the European Union, allowing each member state to establish its own flavor regulations.

 

However, according to Latvia's recommendations, individual bans are ineffective because "there is no complete ban on cross-border remote sales of tobacco or related products (including e-cigarettes) at the EU level, and cross-border sales are not prohibited.

 

Due to continued discrepancies among member states in the regulation of flavors and additives in e-cigarette liquids, as well as cross-border distance sales, it is necessary to establish further common regulations at the EU level.

 

Denmark's proposal calls for stricter requirements and urges the European Union to allow member states to ban specific categories of nicotine products.

 

These initiatives should include a ban on flavored nicotine products, restrictions on nicotine content in these products, and the ability to prohibit certain products when necessary. More broadly, we call on the European Commission to initiate a debate on nicotine products and allow for a review of various possible regulations that would enable member states to potentially ban defined product categories.

 

The European Tobacco Harm Reduction Advocates (ETHRA) has written a letter to all EU health ministers, opposing the proposed flavor ban and explaining its consequences. "We hope to proceed cautiously in the discussion and provide some factual background. The proposed measures are unlikely to protect young people and may have more disadvantages than benefits. A total or partial ban on the production and supply of new nicotine products will not eliminate the basic demand for nicotine. All safer nicotine products have some form of flavor (including tobacco flavor), so a flavor ban is effectively a substantial ban on the products.

 

Prohibition will not make the banned products disappear or diminish demand.

 

ETHRA has provided four strategies to reduce teenagers' exposure to e-cigarettes and other nicotine products:

  • Legal regulated market; 
  • Age verification retail system; 
  • Marketing control; 
  • Taste description control. 

 

The organization is calling on EU health ministers to base the upcoming revision of the major EU Tobacco Products Directive on "evidence, careful consideration, and meaningful consultation.

 

These directives could have life-threatening or life-saving implications for European citizens, and we should not begin revising based on preconceived outcomes that rely on weak or misleading evidence.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
U.S. Food and Drug Administration’s Center for Tobacco Products held a formal listening session with IKE Tech LLC to discuss youth prevention at the point of use for ENDS products, the circulation of illicit products in the supply chain, and the regulatory treatment of software in tobacco products.
Apr.10 by 2FIRSTS.ai
EVO NXT: two days, four zones, countless opportunities
EVO NXT: two days, four zones, countless opportunities
Mar.30
U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
North Carolina hemp provider JLT Imports Inc. has filed suit in California federal court seeking cancellation of the “Lost Mary” vape trademark held by Chinese company Imiracle (HK) Ltd.
Mar.30 by 2FIRSTS.ai
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea said on April 29 that it has appointed Lee Hong-seok, head of its smoke-free products division, as its new chief executive officer, with his term beginning on May 1. Yoon Hee-kyung, who took office in 2023, will step down after about three years in the role.
Apr.30 by 2FIRSTS.ai